XDNASE Trademark

Trademark Overview

On Tuesday, January 25, 2022, a trademark application was filed for XDNASE with the United States Patent and Trademark Office. The USPTO has given the XDNASE trademark a serial number of 97236766. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, August 21, 2024. This trademark is owned by XENETIC BIOSCIENCES, INCORPORATED. The XDNASE trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Cells for medical or clinical use; Therapeutic agents for medical or clinical use in the nature of cancer treatment, namely, protein therapeutics

Cells for scientific and research use
xdnase

General Information

Serial Number97236766
Word MarkXDNASE
Filing DateTuesday, January 25, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements

Goods and ServicesCells for medical or clinical use; Therapeutic agents for medical or clinical use in the nature of cancer treatment, namely, protein therapeutics
Goods and ServicesCells for scientific and research use

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, January 28, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXENETIC BIOSCIENCES, INCORPORATED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFramingham, MA 01701
Party NameXENETIC BIOSCIENCES, INCORPORATED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFramingham, MA 01701

Trademark Events

Event DateEvent Description
Wednesday, September 28, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, January 28, 2022NEW APPLICATION ENTERED
Friday, January 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 3, 2022ASSIGNED TO EXAMINER
Monday, November 7, 2022NON-FINAL ACTION WRITTEN
Monday, November 7, 2022NON-FINAL ACTION E-MAILED
Monday, November 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 10, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 8, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 8, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 8, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, May 8, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 31, 2024SOU EXTENSION 1 FILED
Wednesday, January 31, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 31, 2024SOU EXTENSION 1 GRANTED
Wednesday, August 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU EXTENSION 2 GRANTED
Wednesday, August 21, 2024SOU EXTENSION 2 FILED
Friday, February 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

xdnase cells clinical medical protein therapeutics research namely scientific cancer therapeutic